Accessibility Tools
Carlene MacMillan, MD, FCTMSS, DFAACAP

Carlene MacMillan, MD, FCTMSS, DFAACAP

Dual Board-Certified,
Child Adolescent and Adult Psychiatrist
Interventional Psychiatrist

Interventional Psychiatrist

Carlene MacMillan, MD, FCTMSS, DFAACAP, is a dual board-certified child, adolescent and adult psychiatrist, and the Chief Medical Officer at Osmind, a platform that enables clinicians to deliver breakthrough mental health treatments. She completed her undergraduate and medical degrees at Havard and then went on to complete residency and fellowship at Harvard's MGH/McLean Hospital. She is on the Board of Directors of the Clinical TMS Society and the Co-Chair of the CTMSS Insurance Committee. She is the Co-Chair of the American Academy of Child and Adolescent Psychiatry Consumer Issues Committee. Dr.MacMillan is on the board of the Ketamine Taskforce for Access to Safe Care and Insurance Coverage. She participates in real world evidence and post-marketing studies of transcranial magnetic stimulation and esketamine. She is extensively trained in Mentalization Based Treatment and applies it in individual, group therapy, family and team/systems settings.

As a psychiatric futurist, she speaks regularly at a wide range of conferences from the American Psychiatric Association to SXSW and to the media on a wide range of topics from psychedelic medicine to health tech innovations. Prior to Fermata, she was the inaugural Medical Director of the NYC Ellenhorn Private Assertive Community Treatment program and the founder of Brooklyn Minds, a groundbreaking high acuity outpatient mental health group practice which was acquired by Curated Mental Health in 2022. She is a mom to two amazing twins, one of whom also wants to be a “feelings doctor” who is “good at technology” when she grows up. She is licensed in NY, MA, NJ, CA, MS and TX.

Education

  • 2003 BA Psychology Harvard College

  • 2009 MD Medicine Harvard Medical School

Postdoctoral Training

  • 2010 Pediatrics/Psychiatry Internship Massachusetts General Hospital/McLean Hospital

  • 2012 Adult Psychiatry Residency Massachusetts General Hospital/McLean Hospital

  • 2014 Child & Adolescent Psychiatry Fellowship Massachusetts General Hospital/McLean Hospital

Licensure and Certification

  • 2009-2010 Limited Massachusetts Medical License

  • 2010-Present Full Massachusetts Medical License

  • 2009-Present National Provider Identification Number

  • 2013-Present Diplomate of the American Board of Psychiatry and Neurology in Adult Psychiatry

  • 2015-Present Diplomate of the American Board of Psychiatry and Neurology in Child and Adolescent Psychiatry

  • 2012-Present DEA Licenses with Suboxone Waiver:

  • 2010-Present Massachusetts Controlled Substance Registration

  • 2014 Mentalization Based Treatment for Borderline Personality Disorder Intensive Training

  • 2014 Mentalization Based Treatment-Family (MBT-F) Training

  • 2014 Good Psychiatric Management for Borderline Personality Disorder (GPM) Train the Trainers Training

  • 2015-Present New York State Full Medical License

  • 2015 Mentalization Based Treatment for Adolescents Training

  • 2016 Mentalization Based Therapy Practitioner/Supervisor Level Training

  • 2016 Adaptive-Mentalization Based Integrative Treatment Train the Trainers Training

  • 2017 Integrative Harm Reduction Training

  • 2017 Deep Transcranial Magnetic Stimulation Operator Training, Brainsway, Inc. for H-1 Coil

  • 2018 Deep Transcranial Magnetic Stimulation Operator Training, Brainsway, Inc for H-7 Coil

  • 2019 Mentalization Based Treatment for Children Training

  • 2019- Present California Full Medical License

  • 2021- Present NJ Full Medical License

  • 2022- Present Texas Full Medical License

  • 2022- Present Mississippi Full Medical License

  • 2023- Present Florida Telehealth Medical License

Dr. MacMillan is licensed in:

  • New York
  • New Jersey
  • Mississippi
  • Connecticut
  • Massachusetts
  • California
  • Texas
  • Florida (Telehealth Only)

Academic Appointments

  • 2009-2014 Clinical Fellow in Psychiatry Harvard Medical School

  • 2014-2015 Instructor in Psychiatry Harvard Medical School

  • 2015-2016 Assistant Clinical Professor NYU Langone Medical

Hospital Appointments

  • 2011-2013 Moonlighter, Clinical Evaluation Center McLean Hospital

  • 2012-2014 Fellow, Child & Adolescent Psychiatry Franciscan’s Hospital

  • 2013 Psychiatrist-On-Call Newton Wellesley Hospital

  • 2013-2015 Psychiatrist-On-Call Mount Auburn Hospital

  • 2014-2015 Staff Psychiatrist McLean Hospital

  • 2015-2016 Staff Psychiatrist NYU Langone Medical Child Study Center

  • 2016-2022 CEO & Founder Brooklyn Minds Psychiatry

Other Professional Positions and Visiting Appointments

  • 2012-2015 Sole Proprietor Private Psychiatric Practice

  • 2003-2005 Clinical Study Coordinator Children’s Hospital Boston

  • 2016-2019 Ellenhorn NYC PACT Medical Director

  • 2017-2019 Arista MD Online Child and Adolescent Psychiatry E-Consults

  • 2021-2023 RubiconMD/ Oak Street Health Collaborative Care Clinical Consultant

  • 2021-2022 Medical Director, Product and Growth, Osmind

  • 2022-2022 VP of Clinical Innovation, Osmind

  • 2022-Present Chief Medical Officer, Osmind

  • 2022-Present Fermata, Co-Founder

  • 2023-Present Total Life, P.C owner

Memberships, Offices, And Committee Assignments in Professional Societies

  • 2005-2015 Massachusetts Medical Society, Member

  • 2007-2015 Massachusetts Psychiatric Society, Member

  • 2011-2013 Massachusetts Psychiatric Society College Mental Health Committee, Co-Chair

  • 2013-2015 Massachusetts Psychiatric Society Designated DSM-5 Trainer

  • 2014-2015 Massachusetts Psychiatric Society Council Member

  • 2007-Present American Psychiatric Association Member

  • 2014-2015 American Psychiatric Association Area 1 Assembly Representative(voting position)

  • 2012-Present American Academy of Child and Adolescent Psychiatry, Member

  • 2012-Present American Academy of Child and Adolescent Psychiatry Consumer Issues Committee Member

  • 2013-2018 North American Society for the Study of Personality Disorders,Member

  • 2015-Present New York County Psychiatric Society, Member

  • 2015-Present New York Council on Child and Adolescent Psychiatry, Member

  • 2017-Present Clinical TMS Society Member

  • 2018-Present Clinical TMS Society Insurance Committee Member

  • 020-Present American Academy of Child and Adolescent Psychiatry Consumer Issues Co-Chair

  • 2022-Present American Psychedelic Practitioners Association, Member

  • 2022-Present Clinical TMS Society Insurance Committee Co-Chair

  • 2023-Present Clinical TMS Society Board of Directors

  • 2023-Present APA Caucus on Neuromodulation

  • 2023-Present American Psychiatric Association Committee on Quality and Performance Measurement Corresponding Member

  • 2023 Taskforce on AACAP’s Relationship with the Biomedical Industry

  • 2023-Present American Society of Ketamine Physicians, Psychotherapists and Practitioners, Member

  • 2023-Present American Society of Ketamine Physicians, Psychotherapists and Practitioners, Expert Faculty Member

  • 2023-Present New York County Psychiatric Society Technology Committee Co- Chair

  • 2023-Present American Psychiatric Association Standing Workgroup on Measurement-Based Care

Major Committee Assignments

  • 2006-2007 Psychiatry Student Interest Group, Co-Chair, Harvard Medical School

  • 2007-2009 Residency Advisory Council on Medical Education in Psychiatry, Student Representative, Harvard Medical School

  • 2010-2012 Adult Psychiatry Residency Program Internal Website Committee, Co-Chair, Massachusetts General Hospital

  • 2012-2014 Child and Adolescent Psychiatry Residency Program Internal Website Committee, Founder and Co-Chair, Massachusetts General Hospital

  • 2022-2023 Brain Futures: Psychedelic Assisted Therapy Coding And Reimbursement Working Group

  • 2023-Present CMS Partnership for Quality Measurement Pre-Rule Making Measure Review Committee

  • 2023-Present National Quality Forum Research, Development and Solutions Council

Major Administrative Leadership Positions

  • 2013-2014 Chief Resident in Child & Adolescent Psychiatry, Massachusetts General Hospital

  • 2016-2022 Founder and CEO of Brooklyn Minds Psychiatry

  • 2018-2022 CEO of Mind Centers, Inc, a Medical Service Organization

  • 2022-2022 VP of Clinical Innovation, Osmind

  • 2022-Present Co-Founder and CEO, Fermata

  • 2022-Present Chief Medical Officer, Osmind

Principal Clinical and Hospital Service Activities

  • 2012-2015 Private Psychiatric Practice for Adults and Children

  • 2014-2015 Inpatient Attending Psychiatrist, Trauma & Dissociative Unit, McLean Hospital

  • 2014-2015 Psychiatrist and Multi-Family DBT Group Leader for 3East Outpatient Adolescent DBT Program, McLean Hospital

  • 2014-2015 Supervising Psychiatrist, Clinical Evaluation Center, McLean Hospital

  • 2015-2016 Outpatient Attending Psychiatrist, NYU Child Study Center, Manhattan and Long Island

  • 2016-2019 Medical Director at Ellenhorn NYC PACT Team, NYC, NY

  • 2016-2022 Clinical Director of Multi-disciplinary, Multi-location Psychiatric Practice, Brooklyn Minds, Brooklyn, NY

  • 2022-Present Fermata, Private practice psychiatrist offering TMS, esketamine, psychiatric services

Awards and Honors

  • 2003 Elizabeth Cary Agassiz Award Radcliffe College

  • 2003 Magna Cum Laude with Highest Honors in Psychology Harvard College

  • 2006 Donald J. Cohen KTGF Medical Student Fellowship in Child & Adolescent Psychiatry Harvard Medical School

  • 2009 Joseph M. Martin Loan Forgiveness Award for Psychiatry Harvard Medical School

  • 2012 Educational Outreach Award American Academy of Child & Adolescent Psychiatry

  • 2013 Junior Scholar Annual Meeting Award American Academy of Child & Adolescent Psychiatry

  • 2014 APA Resident Recognition Award American Psychiatric Association

  • 2021 Creator First Inaugural Class Member Clubhouse

Invited Presentations and Grand Rounds

  • 2013 Created and Presented CME programming on the DSM-5, Massachusetts Psychiatric Society District Branch Chapters, North Suffolk Mental Health, and Cambridge Adolescent Consultation Services, 8 hours, psychiatrists and behavioral health practitioners at all levels of training across the state

  • 2014 Created and presented webinar on the DSM-5 to be included in Board Review Course and Modern Psychiatry Course, Massachusetts General Hospital Psychiatry Academy, 1 hour, multi-disciplinary online viewers

  • 2014 Invited Presenter of case discussion entitled “More Dating Experience than Some Celebrities”: Borderline and Narcissistic Personality Disorders in Couples Therapy, McLean Borderline Case Conference, 1 hour, McLean Borderline Center Clinicians

  • 2014 Invited Lecturer on the DSM-5 for Current Trends In Psychiatry Live Program, Massachusetts General Hospital Academy, 1 hour, ~90 psychiatrists from Brazil

  • 2014 Grand Rounds on Emerging Borderline Personality Disorder in Adolescents, Franciscan’s Hospital for Children, 1 hour, multi-disciplinary group (social workers, nurses, psychologists, psychiatrists)

  • 2015 Grand Rounds on the DSM-5 for Pediatric Mental Health Practitioners, Franciscan’s Hospital for Children, 1 hour, multi-disciplinary group (social workers, nurses, psychologists, psychiatrists)

  • 2015 Developed Training Webinar on the use of DSM-5 and ICD-10 codes for Behavioral Health Practitioners, Partners Healthcare, 2 hours, all behavioral health providers in the Partners Hospital System

  • 2015 Gave webinar for parents to help their children become good digital citizens, 30 minutes, NYU Child Study Center

  • 2016 Co-Presented on Pharmacogenomics in Psychiatry as part of a Parent Workshop series, 2.5 hours, NYU Child Study Center

  • 2016 Presented to Trainees on Private Practice as part of NY Council on Child and Adolescent Psychiatry’s Career night, 2 hours, NYC

  • 2017 Grand rounds on Emerging Borderline Personality Disorder, 4 hours, Mercy Hospital Annual Pediatric Psychiatry Conference, Mercy Hospital, St. Louis, MO, April 27th 2017 (with Owen Muir, M.D.)

  • 2017 Presented on Adapative Mentalization Based Integrative Treatment (AMBIT) at a series of Lunch & Learn events hosted by Ellenhorn NYC for area clinicians, 4 hours, NYC

  • 2018: Presented “Introduction to AMBIT: Mentalization Based Treatment for Teams” at Mentalization, DBT & Attachment: Treatment for Adults and Adolescents conference, Newton, MA

  • 2018 Presented on Mentalization Based Treatment for TARA Family Education for BPD Series, New York, NY

  • 2019 Presented on AMBIT with Peter Fuggle on behalf of the Anna Freud National Centre for Children and Families to the Lourie Center for Children’s Social and Emotional Wellness, Rockville, MD

  • 2019 Presented on “Leading the Way to Better Mental Health Care in New York” at Psychiatry Network 2019 Womens Physician Conference, Leesburg, VA

  • 2020 Presented on “Caring for High-Risk Clients during Covid-19” for Alma, webinar, www.helloalma.com

  • 2021 Presented on “How to Best Utilize the New CTMSS Recommended OCD Coverage Policy” for Clinical TMS Society, Webinar

  • 2022 Presented on “Psychedelic Medicine and Technology: How Digital Applications Can Help Better Serve Patients” for the Psychedelic Medicine Association, Webinar

  • 2022 Presented on “Mental Health & the Holidays: Patient Crises, Technology & Time Off” for Spruce Health webinar

  • 2022 Presented on “An Operating System for Neuropsychiatry that Enables Evidence Generating Medicine” at the Metabolic Psychiatry Roadmap Retreat, Santa Barbara, CA

  • 2023 Panelist on “Lost without a GPS: The promise and limitations of digital measurements” at Cornell Tech Behavioral Health Next Summit, New York, NY

  • 2023 Presented on “Mind the Machines: Technology and Mental Health” at SXSW, Austin, Tx

Medical Education

  • 2011 Guest Lecturer on Introduction to Psychopharmacology, Simmons College, 1 hour lecture, undergraduate students

  • 2013 Lectured on using Harry Potter to teach principles of resiliency and attachment in children, Massachusetts General Hospital, 3 hours, Pediatrics Residents, Child & Adolescent Psychiatry Fellows

  • 2014- 2019 Lectured on starting a private practice, Massachusetts General Hospital, 1 hours, Adult Psychiatry Residents. Repeated annually

  • 2013 Presented on DSM-5 for Child Psychiatrists, McLean Hospital, 90 minutes, Child Psychiatry Fellows from MGH, Cambridge Hospital and Children’s Hospital Boston

  • 2015 Developed and Co-taught Introduction to Psychotherapy Workshop, Massachusetts General Hospital, 6 hours, Adult Psychiatry Interns

  • 2016 Lectured 1st year Child Psychiatry fellows on Self-injurious Behavior and Suicidality in children and adolescents, 3 hours, NYU

  • 2017- Present: Present to Child Psychiatry Fellows at SUNY Downstate on suicidality, self-harm and borderline personality disorder in adolescents, 4 hours, Brooklyn. Present annually on this topic.

  • 2018 “Sex-Positive Culture: A Primer,” Hunter College Graduate Masters of Social Work Program, 1 hour, with Dr.Owen Muir, New York, NY

  • 2018- Present: Present to Child Psychiatry Fellows at SUNY Downstate on starting a private practice ,1 hour, Brooklyn. Present annually on this topic.

  • 2021 Presented on career path as a child psychiatrist turned Silicon Valley tech company executive to child psychiatry fellows at Children’s Hospital Boston

Mentoring of Graduate Students, Residents, Post-Doctoral Fellows

  • 2015-2016 Supervision of 2nd year Child Psychiatry Resident (1 hour/week)

  • 2017-2018 Supervision of Mental Health Clinician working towards licensure (1 hour/ week)

  • 2017- 2022 Supervision of Post-Doctoral fellows (1 hour/week)

  • 2023-Present PsychSIGN mentor to 2 medical students (6 hours/year)

Teaching Awards Received

  • 2013 Highest Rated Members’ Forum Presentation (peer rating), American Academy of Child and Adolescent Psychiatry Annual Meeting

Major Research Interests

At present, I identify as an executive clinician leader in healthtech and educator with an interest in emerging breakthrough treatments for severe mental illness, including rapid acting antidepressants, neuromodulation, digital therapeutics and psychedelic medicine.I work closely with technologists, product leaders and data scientists on the infrastructure needed to support the wide scale deployment of these treatments that leverages measurement based care to provide real world evidence/post-marketing data to further our understanding of what works for whom. In addition, I am committed to the use of technology to increase access to breakthrough treatments by utilizing outcomes data and data on utilization of care to advocate for more widespread payer coverage of these treatments. In addition, I have a longstanding interest in complex psychiatric conditions, especially personality disorders and the use of mentalization based treatment on an individual, group and systems level for this population

Boards and Community Organizations

  • 2017-2018 Emotions Matter, Inc.- Co-Chair of Clinical advisory committee for this 501 (c)3 non-profit focused on borderline personality disorder

  • 2018-2019 Emotions Matter, Inc- Board seat and Co-Chair of the Education Committee

  • 2020-2021 Clinical Advisory Board, Osmind

  • 2021-Present VP on Board of Ketamine Taskforce for Access to Safe Care and Insurance Coverage

  • 2023-Present Clinical TMS Society Board of Directors

  • 2023-Present Co-Chair Osmind Community Advisory Board

Bibliography

Original Reports

Gonzalez-Heydrich J, Whitney J, Waber D, Forbes P, Hsin O, Faraone SV, Dodds A, Rao S, Mrakotsky C, Macmillan C, Demaso DR, de Moor C, Torres A, Bourgeois B, Biederman J. Adaptive phase I study of OROS methylphenidate treatment of attention deficit hyperactivity disorder with epilepsy. Epilepsy and Behavior. 2010;18(3): 229-237.

Gonzalez-Heydrich, J, Dodds A, Whitney J, Macmillan C, Waber D, Faraone S, Boyer S, Mrakotsky C, DeMaso D,Bourgeois B, Biederman J. Psychiatric Disorders and Behavioral Characteristics of Pediatric Patients with Epilepsy and ADHD. Epilepsy and Behavior. 2007;10(3): 384-388.

Harmelech T, Tendler A, Arikan MK, Çetin HL, Esmeray MT, Ilhan R, Vidrine R, Muir O, Macmillan C, Sinclair R, Shakir S, Kent D, Evangelidis N, Roth Y. Long-term outcomes of a course of deep TMS for treatment-resistant OCD. Brain Stimulation. 2022; 15(1):226-228.

Macmillan CM. In Transitional Space: A Whirlwind Tour of the DSM-5. Adolescent Psychiatry. 2013; 3(4): 293-296.

Macmillan CM, Whitney J, Korndörfer SR, Tilley CA, Mrakotsky C, Gonzalez- Heydrich JM. Comparative Clinical Responses to Risperidone and Divalproex in Patients with Pediatric Bipolar Disorder. Journal of Psychiatric Practice. 2008; 14(3): 160-169.

Macmillan CM, Korndörfer SR, Rao S, Fleisher CA, Mezzacappa E, Gonzalez- Heydrich J. A Comparison of Divalproex and Oxcarbazepine in Aggressive Youth with Bipolar Disorder. Journal of Psychiatric Practice. 2006; 12(4), 214-222.

Macmillan CM, Gonzalez-Heydrich J. Oxcarbazepine is no more effective than placebo for reducing manic symptoms of bipolar I disorder in children and adolescents. Evidence Based Mental Health. 2007; 10(2): 59.

Macmillan CM. “The Father of BPD” John Gunderson, 1942-2019. Journal of the American Academy of Child and Adolescent Psychiatry. 2019; 58(5):544-545.

Muir O,Weinfeld J, Ruiz D, Ostrovsky D, Fiolhais M, Macmillan C. Mental Health Clinicians’ Attitudes Towards Narcissistic Personality Disorder. 2021; 12 (5): 389-399.

Peek HS, Richards M, Muir O, Chan SR, Caton M, Macmillan C. Blogging and Social Media for Mental Health Education and Advocacy: a Review for Psychiatrists. Current Psychiatry Reports. 2015; 17 (11): 88 Roth, Y, Tendler, A, Arikan, K, Vidrine, R, Kent, D, Muir, O, Macmillan C, Casuto, L, et al., Real-World Efficacy of deep TMS for Obsessive-Compulsive Disorder: Post-Marketing Data Collected from Twenty-two Clinical Sites. Journal of Psychiatric Research. 2021, 137:667-672.

Tendler A, Goerigk S, Zibman S, Ouaknine S, Harmelech T, Pell G, Zangen A, Harvey S, Grammer G, Stehberg J, Adefolarin O, Muir O, Macmillan C, Ghelber D, Duffy W, Mania I, Faruqui Z, Munasifi F, Antin T, Padberg F, Roth Y. Deep TMS H1 Coil Treatment for Depression: Results From a Large Post Marketing Data Analysis. Psychiatry Research. 2023, 324: 115179.

Zuckerman ML, Vaughan BL, Whitney J, Dodds A, Yakhkind A, Macmillan C, Raches D,Pravdova I, DeMaso D, Beardslee WR, Gonzalez-Heydrich J:Tolerability of Selective Serotonin Reuptake Inhibitors in Thirty-nine Children Under Age Seven. A Retrospective Chart Review. Journal of Child and Adolescent Psychopharmacology. 2007; 17(2): 165-174

Reviews, Books and Book Chapters

Macmillan C: Book Review: Beautiful Boy: A Father’s Journey Through his Son’s Addiction and Tweak. Journal of the American Academy of Child and Adolescent Psychiatry. 2015; 54 (5): 426-428.

Macmillan C, Muir O: Book Chapter: Good Psychiatric Management for the Care of the Adolescent in Borderline Personality, a Case Based Approach, Unruh B, Palmer B, editors, Springer Publishingx, 2018

Macmillan C : Book Chapter: MBT Plays Well with Others in Adolescent Suicide and Self-Injury: Mentalizing Theory and Treatment, Muir O, Williams L, editors, Springer Publishing, 2020

Wrzosek, M, Macmillan C: Book Review: The Book of Woe: The DSM and the Unmaking of Psychiatry. Journal of the American Academy of Child and Adolescent Psychiatry.2014; 53(9): 1031-1032.

Educationally Relevant Publications

Macmillan C. Staying Strong Together: Fostering Resiliency in Military- Connected Families. AACAP News. May-June 2013.

Macmillan C In Transitional Space Column: A Whirlwind Tour of the DSM-5. Massachusetts Psychiatric Society Member Newsletter. 2013;6:4.

Macmillan C. In Transitional Space Column: “Super Angry, Grouchy, and Cranky”: Examining the Addition of Disruptive Mood Dysregulation Disorder to the DSM-5. Massachusetts Psychiatric Society Member Newsletter. 2013;137:

Macmillan C. In Transitional Space Column. Do Old (Diagnostic) Habits Die Hard?: Substance-Related anD Addictive Disorders in the DSM-5. Massachusetts Psychiatric Society Member NewsletterIssue.2013;138.

Macmillan C. In Transitional Space Column. Moving from Caricatures to Characters?: Personality Disorder And the DSM-5.2013; 139.

Macmillan C. In Transitional Space Column: Better Bring Your Umbrella: Autism Spectrum Disorders in the DSM-5. Massachusetts Psychiatric Society Member Newsletter. 2014;140.

Macmillan C. In Transitional Space Column: Good Grief? Saying Goodbye to the Bereavement Exclusion in DSM-5. Massachusetts Psychiatric Society Member Newsletter. 2014;141.

Hartselle, S., Macmillan C. Members Forum: Ethical and Practical Considerations of Working with the Media: Review of Conference Presentation. AACAP News. 2014.

Macmillan C. In Transitional Space Column: Rethinking “It’s All in Your Head: The DSM-5 Somatic Disorders Section. Massachusetts Psychiatric Society Member Newsletter.2014;143.

Proceedings of Meetings

Chen, JA, MacMillan, CM, Kroll, SD: “The Future Is Here: Innovative Models of Outpatient Psychiatric Service Delivery.” Presented at the American Psychiatric Association Annual Meeting, New Orleans, LA, May 2022.

Fritsch,SL, Mao, AR, Belfort, EL, MacMillan, CM, Vana, G: Helping Parents Guide their Children to Use Social Media Safely: Do’s and Don’t’s. Workshop presented at the American Academy of Child and Adolescent Psychiatry Annual Meeting, San Diego, CA, Oct 2014.

Fritsch,SL, Belfort,EL, Mao,AR, MacMillan,CM: “Adding Social Media to the Psychiatrist’s Toolkit” as part of Working with Families and Teens about Using Social Media Wisely, Clinical Perspectives presented at the American Academy of Child and Adolescent Psychiatry Annual Meeting, San Antonio, TX, Oct 2015.

Fritsch S, MacMillan C, Muir O, Gerwin R, Belfort E: “Off the Couch and Onto the Internet” workshop presented at the American Academy of Child and Adolescent Psychiatry Annual Meeting, New York, NY, Oct 2016.

Fritsch S, MacMillan C, Muir O, Sparks G: “Practical Tools for Clinicians in the Digital Era” Ticketed Workshop at the American Academy of Child and Adolescent Psychiatry Annual Meeting, Seattle, WA Oct 2018

Kim, C, Domakonda, M, Nakshabandi, F, MacMillan, C: Open for Business: Practical Tips on Private Practice for Early-Career Psychiatrists. Member Services forum presented at the American Academy of Child and Adolescent Psychiatry Annual Meeting, Toronto, CA Oct 2022

Kim, C, MacMillan, C, Webster, C, Nakshabandi, F : Open for Business: Practical Tips on Private Practice for Early-Career Psychiatrists. Member Services forum presented at the American Academy of Child and Adolescent Psychiatry Annual Meeting, New York, NY Oct 2023

MacMillan, CM, Short, EB: Lessons Learned From U.S. Insurance. Presented at the Clinical TMS Society Annual Meeting, Colorado Springs, CO May 2023 MacMillan, C, Williams, N, Muir, O, Lipov, E: Navigating What’s Next in Interventional Psychiatry. General session presented at the American Psychiatric Association Annual Meeting, San Francisco, May 2023

MacMillan C, Muir O, Nouvini R, Hassuk B, Perepletchikova F: “Confidently Approaching Borderline Personality Disorder in Young People: A Primer for the General Child and Adolescent Psychiatrist” Clinical Perspectives presented at the American Academy of Child and Adolescent Psychiatry Annual Meeting, New York, NY, Oct 2016.

MacMilllan C, Hartselle, S: Ethical and Practical Considerations of Working with the Media, Member Services Forum presented at the American Academy of Child and Adolescent Psychiatry Annual Meeting. Orlando, FL, Oct 2013.

MacMillan, C.: Addressing Misconceptions Amongst Child and Adolescent Psychiatrists about Borderline Personality Disorder, presented at the North American Society for the Study of Personality Disorders Annual Meeting, April 2017, NY, NY.

MacMillan, C: First, Do No Harm: Thoughtful prescribing practices for young People with Emerging Personality Disorders, Clinical perspective presented at the American Academy of Child and Adolescent Psychiatry Annual Meeting, Washington, DC, Oct 2017.

MacMillan, C: Online Sexual Communications in Adolescents: Risks and Realities. Clinical perspectives presented at the American Academy of Child and Adolescent Psychiatry Annual Meeting, Washington, DC, Oct 2017.

Muir, OS, MacMillan, CM, Schlozman, S, Kaneko, Y: Moonrise Kingdom: Wes Anderson’s Ode to the Resilient Adolescent, Media Theatre presented at the American Academy of Child and Adolescent Psychiatry Annual Meeting, San Diego, CA, Oct 2014.

Muir, OS, MacMillan, CM, Winsberg,M, Hoffman, P: Telehealth Solutions for Crisis Management in the Acute Care Setting, General Session presented at the American Psychiatric Association Annual Meeting, San Francisco, CA, May 2023.

Peek, H, MacMillan, C, Beresin, E, Schlozman, S, Cox, Laura. Blogging, Linking, Liking & Following: A Psychiatrist’s Guide for Using Social Media and Blogging for Mental Health Education and Advocacy, Workshop presented at the American Psychiatric Association Annual Meeting, Toronto, Canada, May 2015.

Williams, L, Muir, O. Fleisher, C, Bleiberg,E, Grimes, C, MacMillan, C, Cracknell, L, Bevington, D. Extended Workshop on Fundamentals in Mentalization-Based Treatment for Suicidal And Self-injurious Youth, presented at the American Academy of Child and Adolescent Psychiatry Annual Meeting, Washington, DC, Oct 2017.

Williams L, Muir O, Bleiberg E, Grimes C, MacMillan C, Fleisher C. Basic Concepts in Mentalization Therapy with Adolescents with Emerging Personality Disorders and Self-Harming Behaviors Ticketed Workshop presented at the American Academy of Child and Adolescent Psychiatry Annual Meeting, Seattle, WA, Oct 2018

Williams, L, Muir, O. Fleisher, C, Bleiberg,E, Grimes, C, MacMillan, C, Cracknell, L,McEvoy K. Extended Workshop on Fundamentals in Mentalization-Based Treatment for Suicidal And Self-injurious Youth, presented at the American Academy of Child and Adolescent Psychiatry Annual Meeting, Seattle WA, Oct 2018

Williams, L, Fleisher, C, Grimes, C, Bleiberg, E, MacMillan, C, Muir, O, Ruiz, D. Extended Workshop on Fundamentals in Mentalization-Based Treatment for Suicidal And Self-injurious Youth, presented at the American Academy of Child and Adolescent Psychiatry Annual Meeting, Chicago IL, Oct 2019

Williams L, Fleisher, C, Muir, O, MacMillan, C, Bleiberg, E, Grimes, C. Basic Concepts in Mentalization Therapy with Adolescents with Emerging Personality Disorders and Self-Harming Behaviors Ticketed Workshop presented at the American Academy of Child and Adolescent Psychiatry Annual Meeting, Chicago, IL, Oct 2019

Williams L, Muir, O, Grimes, C, MacMillan, C, Fleisher, C. Basic Concepts in Mentalization Therapy with Adolescents with Emerging Personality Disorders and Self-Harming Behaviors Ticketed Workshop presented at the American Academy of Child and Adolescent Psychiatry Annual Meeting, Held online due to Covid-19, Oct 2020

Williams, L, Fleisher, C, Muir, O, MacMillan, C, Bleiberg, E, Grimes,C.: “Difficult” Patients and Healing in the Disinformation Age: Mentalizing as a Transdiagnostic Approach To Emotion Dysregulation and to Mistrust of Facts Extended Ticketed Workshop presented at the American Academy of Child and Adolescent Psychiatry Annual Meeting, Toronto, CA Oct 2022

Williams L, Muir, O, Grimes, C, MacMillan, C, Fleisher, C, Bleiberg, E.. Basic Concepts in Mentalizating-Based Therapy for Adolescents with Mood Dysregulation Ticketed Workshop presented at the American Academy of Child and Adolescent Psychiatry Annual Meeting, New York, NY

Abstracts

Hsin O, Miller TP, MacMillan C, Johnson F, Gonzalez-Heydrich J: Ziprasidone In Pediatric Patients: Efficacy and Tolerability. Poster presented at World Psychiatric Association International Congress. Florence, Italy, Nov 2004.

Korndörfer SR, MacMillan CM, Fleisher C, Beardslee WR, Gonzalez-Heydrich J: Comparison of divalproex and gabapentin: Effectiveness in aggressive youth. Poster presented at 16th European College of Neuropsychopharmacology Congress. Prague, Czech Republic, Sep 2003.

Korndörfer SR, MacMillan CM, Fleisher CA, Mezzacappa E, Beardslee W, Gonzalez-Heydrich J: A Comparison of Divalproex, Gabapentin and Oxcarbazepine in Aggressive Youth. Poster presented at New Clinical Drug Evaluation Unit (NCDEU) meeting. Phoenix, AZ, Jun 2004.

MacMillan CM, Gralinski-Bakker, JH (Adviser), Keel, P(Adviser): Style and Substance: Correlating Preschoolers' Play Narratives with Externalizing Problems, poster presented at Harvard University Mind, Brain, Behavior Senior Thesis Symposium and at Harvard University Psychology Department Poster Session, Cambridge MA, May 2003.

Muir O, MacMillan C, Sang L, Khan M, Tendler A: Rapid Remission of Depression Using Sequential Bilateral Theta Burst dTMS: Case Report, Presented at Clinical TMS Society Annual Meeting, Vancouver BC, February 2019

Whitney, JE, MacMillan CM, Hsin, O, Miller, TP, Johnson, F, Gonzalez- Heydrich, JM: Tolerability of Olanzapine and Ziprasidone in Youths with Bipolar Disorder, poster presented at the U.S. Psychiatric and Mental Health Congress, Las Vegas, NV, Nov 2005

Carlene MacMillan, MD, FCTMSS, DFAACAP
Newsletter

Sign Up for the Fermata Mailing List!

  • *
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.

Location & Directions

Brooklyn

58 N 9th St #103,
Brooklyn, NY 11249

Mon To Fri 9.00 am to 7.00 pm

Technology Partners